← Back to Clinical Trials
Recruiting NCT06627764

NCT06627764 SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06627764
Status Recruiting
Phase
Sponsor Duke University
Condition Substance Abuse
Study Type INTERVENTIONAL
Enrollment 400 participants
Start Date 2025-06-30
Primary Completion 2028-07-31

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 100 Years
Study Type INTERVENTIONAL
Interventions
SER Familia

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 400 participants in total. It began in 2025-06-30 with a primary completion date of 2028-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to prevent syndemic health conditions by decreasing acculturative stress and promoting resilience via SER Familia (Salud, Estrés y Resilencia en Familias/ Health, Stress, and Resilience in Families), a family-based intervention. SER Familia is a six-session intervention co-developed and delivered by community health workers (CHWs) that uses strategies to reduce acculturative stress, promote resilience, improve parent-child and family level health, while simultaneously helping families maintain strong social networks and better navigate community resources to address social determinants of health (SDOH). More specifically, investigators aim to: 1) Examine the efficacy of SER Familia to prevent or reduce the syndemic comprised of substance abuse, IPV, HIV risk, depression, and anxiety among Parents and Youth; and 2) Identify how individual, family, and community mechanisms of change related to acculturative stress and resilience mediates the effect of SER Familia.

Eligibility Criteria

Inclusion Criteria: * Eligible participants must identify as Hispanic/Latino/a/x/e, * be a first generation immigrant parent or parental figure (Parent) * have a child (Youth) aged 12-17 * speak English and/or Spanish Exclusion Criteria: * Families planning to move within two years will be excluded

Contact & Investigator

Central Contact

Rosa Gonzalez-Guarda, PhD

✉ rosa.gonzalez-guarda@duke.edu

📞 9196132634

Frequently Asked Questions

Who can join the NCT06627764 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 100 Years, studying Substance Abuse. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06627764 currently recruiting?

Yes, NCT06627764 is actively recruiting participants. Contact the research team at rosa.gonzalez-guarda@duke.edu for enrollment information.

Where is the NCT06627764 trial being conducted?

This trial is being conducted at Durham, United States.

Who is sponsoring the NCT06627764 clinical trial?

NCT06627764 is sponsored by Duke University. The trial plans to enroll 400 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology